PLUS THERAPEUTICS, INC. Files 8-K with Material Agreement
Ticker: PSTV · Form: 8-K · Filed: Jun 20, 2025 · CIK: 1095981
| Field | Detail |
|---|---|
| Company | Plus Therapeutics, Inc. (PSTV) |
| Form Type | 8-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, filing
Related Tickers: PSTX
TL;DR
PLUS THERAPEUTICS (PSTX) filed an 8-K on 6/20 reporting a material definitive agreement and equity sales.
AI Summary
On June 17, 2025, PLUS THERAPEUTICS, INC. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and filed financial statements and exhibits. The filing was made on June 20, 2025.
Why It Matters
This 8-K filing indicates a significant new agreement for PLUS THERAPEUTICS, INC., which could impact its financial standing and future operations.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and unregistered sales of equity, which can introduce financial and regulatory risks.
Key Players & Entities
- PLUS THERAPEUTICS, INC. (company) — Registrant
- June 17, 2025 (date) — Earliest event reported
- June 20, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 001-34375 (identifier) — Commission File Number
- 33-0827593 (identifier) — IRS Employer Identification No.
- CYTORI THERAPEUTICS, INC. (company) — Former company name
- MACROPORE INC (company) — Former company name
FAQ
What type of material definitive agreement did PLUS THERAPEUTICS, INC. enter into?
The filing states that PLUS THERAPEUTICS, INC. entered into a 'Material Definitive Agreement' but does not specify the nature of the agreement in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on June 17, 2025.
What are the former names of PLUS THERAPEUTICS, INC. mentioned in the filing?
The former names mentioned are CYTORI THERAPEUTICS, INC. and MACROPORE INC.
What items are covered in this 8-K filing?
This 8-K filing covers 'Entry into a Material Definitive Agreement', 'Unregistered Sales of Equity Securities', and 'Financial Statements and Exhibits'.
What is the principal business address of PLUS THERAPEUTICS, INC.?
The principal business address is 2710 Reed Road, Suite 160, Houston, Texas 77051.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding PLUS THERAPEUTICS, INC. (PSTV).